RING-in-between-RING (RBR) ubiquitin (Ub) ligases are a distinct class of E3s, defined by a RING1 domain that binds E2 Ubconjugating enzyme and a RING2 domain that contains an active site cysteine similar to HECT-type E3s. Proposed to function as RING/HECT hybrids, details regarding the Ub transfer mechanism used by RBRs have yet to be defined. When paired with RING-type E3s, E2s perform the final step of Ub ligation to a substrate. In contrast, when paired with RBR E3s, E2s must transfer Ub onto the E3 to generate a E3~Ub intermediate. We show that RBRs utilize two strategies to ensure transfer of Ub from the E2 onto the E3 active site. First, RING1 domains of HHARI and RNF144 promote open E2~Ubs. Second, we identify a Ub-binding site on HHARI RING2 important for its recruitment to RING1-bound E2~Ub. Mutations that ablate Ub binding to HHARI RING2 also decrease RBR ligase activity, consistent with RING2 recruitment being a critical step for the RBR Ub transfer mechanism. Finally, we demonstrate that the mechanism defined here is utilized by a variety of RBRs.
Introduction
Ubiquitin (Ub) is a small protein involved in the regulation of a wide variety of cellular processes. Ub signaling occurs through the covalent attachment of the Ub C-terminus to protein substrates via a trio of enzymes: a Ub-activating enzyme (E1), a Ub-conjugating enzyme (E2), and a Ub ligase (E3). E1s activate the C-terminus of Ub in an ATP-dependent manner and facilitate the transfer of Ub onto the E2 active site cysteine (Cys) via transthiolation to generate an E2~Ub conjugate ("~" denotes a thioester bond). Most E2~Ub conjugates can pair with one or more E3 Ub ligases to facilitate Ub transfer onto a substrate amino group, usually the side chain of a lysine (Lys). There are three major types of eukaryotic E3 Ub ligases: Really Interesting New Gene (RING)-type E3s (including Ubox E3s), Homologous to E6AP C-Terminus (HECT)-type E3s, and RING-in-between-RING (RBR) E3s.
A majority of E3s are RING-type ligases that use a conserved RING/Ubox domain defined by a characteristic cross-brace fold to bind the E2~Ub. These E3s bind both the substrate and E2~Ub to facilitate Ub transfer from the E2~Ub directly onto a substrate amino group, usually a lysine side chain. In addition to this scaffolding role, RING-type E3s activate the E2~Ub to transfer Ub onto Lys residues (an aminolysis reaction) by promoting closed conformations of the E2~Ub [1] [2] [3] [4] [5] . A crucial feature of the RING-type activation mechanism is a conserved basic residue (Lys/Arg) that contacts both the E2 and the Ub, referred to as the "linchpin" residue [1] . HECT-type E3s bind the E2~Ub via a conserved HECT domain that is structurally distinct from a RING domain. Importantly, HECT-type E3 ligases contain a conserved Cys residue on which an obligatory E3~Ub intermediate is formed prior to Ub transfer onto a substrate Lys. This mechanism requires two types of chemical reactions: (i) a transthiolation reaction transfers Ub from E2~Ub to the E3 active site Cys to generate a reactive E3~Ub species, and (ii) a subsequent aminolysis reaction transfers the C-terminus of Ub from the E3 to a substrate Lys to form a stable isopeptide bond. Unlike the mechanism utilized by RING-type E3 ligases that induce closed E2~Ub conformations, available data on HECT ligases suggest that they do not need a closed E2~Ub for activity [6, 7] .
The third class of E3 ligases was discovered more recently when two RBR E3s, HHARI (human homologue of Ariadne) and Parkin, were shown to function via a RING/HECT hybrid mechanism [6] . Despite containing an eponymous E2-binding RING domain, RBR E3s proceed through an E3~Ub thioester intermediate similar to HECT-type E3s. The functional importance of an active site Cys for catalytic activity has since been confirmed for other RBR E3 ligases including HOIP, HOIL-1L, TRIAD1, and RNF144 [8] [9] [10] [11] . Although a small class with only 12-14 members in the human genome, RBR E3s are involved in many essential cellular pathways. The most studied RBR E3 is Parkin for which mutations have been linked to autosomal recessive juvenile Parkinson's disease [12, 13] . HOIP and HOIL-1L are distinctive for their unique ability to generate linear Ub chains that are crucial regulators of the NF-jB signaling pathway [14] [15] [16] [17] . HHARI and TRIAD1 belong to the Ariadne family of RBR E3 ligases defined by their C-terminal auto-inhibitory Ariadne domain. HHARI and its homologues in Drosophila and C. elegans have been implicated in processes including regulation of translation via the translation initiation factor 4EHP, cellular proliferation, and development [18] [19] [20] [21] . RBR E3s are defined by three characteristic domains each of which coordinates two Zn 2+ ions: RING1, in-between RING (IBR), and RING2. An RBR unit may be found at any position relative to other domains within an RBR E3, but its subdomains RING1-IBR-RING2 always appear in order (N-terminal to C-terminal). RING1 is the E2-binding domain and RING2 contains the active site Cys that when mutated to an alanine (Ala) renders RBRs inactive [6, [8] [9] [10] [11] 22, 23] . While RING1 domains adopt structures similar to canonical RING-type E3 ligases, RING2 domains do not resemble canonical RING domains, either structurally or functionally. The IBR domain adopts a structure that is similar to that of RING2, though its function remains elusive. As mentioned above, canonical RING-type E3s activate an E2~Ub conjugate by promoting closed E2~Ub conformations that exhibit increased reactivity toward the amino groups of Lys residues. A signature of closed conformations are non-covalent interactions between a surface on the E2 formed by the "crossover" helix (also known as helix-2) and the hydrophobic patch or "I44 surface" of Ub. Mutations of residues within the E2:Ub interface abrogate activation by RING-type E3 ligases [1] [2] [3] [4] [5] . Paradoxically, HHARI RING1 fails to activate the E2~Ub for Ub transfer by aminolysis despite its close structural resemblance to canonical RING domains [6] . Furthermore, mutations of the E2 crossover helix that decrease in vitro Ub transfer activity with canonical RING-type E3s do not affect Ub transfer activity of the RBR E3 HHARI [1] . These observations imply that HHARI RING1 is mechanistically distinct from its canonical RING relatives in ways yet to be defined.
RBR E3s such as Parkin, HOIP, and HHARI display activity with a variety of E2s; in particular, they are all active with two wellcharacterized human E2s, UbcH5 and UbcH7 [6, 8, 9] . While most E2s, including UbcH5, are able to perform both transthiolation reactions and aminolysis reactions, UbcH7 solely performs transthiolation reactions [6] . This suggests that UbcH7 can function with HECT-type and RBR-type E3s, but not with RING-type E3s. Notably, C. elegans orthologs of HHARI and UbcH7 act together in pharyngeal development, suggesting that UbcH7 is a biologically relevant E2 for HHARI [20, 24] . But HHARI, Parkin, and HOIP are also known to work with E2s that are able to transfer Ub directly to amino groups. Importantly, HOIP specifically generates linear Ub chains regardless of the chain linkage preference of the E2 with which it works [6, 8, 9, 15, [25] [26] [27] [28] . This suggests a dichotomy in the determining factor for product formation: in the case of RING-type E3s, the identity of the E2 determines the type of product, while in RBR E3s, the E3 determines the type of product. This leads to the question: How do RBR E3s ensure that transfer of Ub occurs via the E3 active cite Cys to maintain control of product formation?
Here, we report the mechanistic strategies used by RBR-type E3s to transfer ubiquitin from the E2 onto the E3. First, we show that RING1 domains of HHARI and RNF144 specifically inhibit closed E2~Ub conformations. This strategy ensures that Ub transfer occurs via the RBR active site by preventing off-target Ub transfer events. Second, we identify a weak but functionally important interaction between HHARI RING2 and Ub which serves to recruit RING2 to the RING1:E2~Ub complex. In structures of auto-inhibited RBR E3s, RING1 and RING2 are far from each other and a large domain rearrangement is required to bring the RING2 active site close to the E2~Ub active site bound to RING1 [29] [30] [31] [32] [33] [34] . Consistent with this notion, mutations in either Ub or RING2 at the Ub:RING2 interface substantially reduce Ub transfer from E2~Ub to RING2. Finally, we demonstrate that the mechanism defined here is utilized by a variety of RBR E3 ligases, indicating its generality for this important class of enzymes.
Results

RBR E3 ligases do not require closed states of E2~Ub for ubiquitin transfer
In the absence of an E3, UbcH5~Ub is highly dynamic, with the Ub moiety populating mainly open states relative to the E2 [35] . Upon binding a canonical RING/Ubox, UbcH5~Ub is biased toward closed states that are activated for aminolysis reactions which constitute the final step in Ub transfer by RING-type E3s. Closed E2~Ub states bound to RING/Ubox domains have been visualized in several cocrystal structures and by NMR [1] [2] [3] [4] . Mutation of a residue on the crossover helix of UbcH5 (L104Q) disrupts formation of closed states and dramatically decreases ubiquitination activity with canonical RINGs such as BRCA1/BARD1 (Fig 1A) N-Ub with the HHARI RING1 domain (residues 177-270). Comparable to previous observations for canonical RINGs, binding of HHARI RING1 to UbcH5-O-Ub occurs in fast-to-intermediate exchange (peaks shift and broaden), indicating that the interaction is of fairly modest affinity (Fig 1B) . CSP analysis of free UbcH5-O-Ub compared to HHARI RING1-bound UbcH5-O-Ub revealed residues that are perturbed upon HHARI RING1 binding. These define a surface composed of residues in helix 1, loops 4 and 7-those known to be central to binding of UbcH5 by canonical RING-type E3s [2, 3, [36] [37] [38] . These results indicate that HHARI RING1 binds UbcH5 in a manner similar to that used by canonical RINGs (Fig 1C) . However, CSPs are not observed for most residues of the UbcH5 crossover helix nor are they observed for the Ub moiety upon HHARI RING1 binding to UbcH5-O-Ub (Fig 1C) . Together, these observations are strong evidence that HHARI RING1 does not promote UbcH5-O-Ub closed conformations. This finding provides a basis for understanding two previous observations: (i) HHARI RING1 does not enhance UbcH5~Ub reactivity toward free Lys [6] and (ii) HHARI RBR exhibits robust activity with the crossover helix mutant UbcH5 L104Q ( [1] and Fig 1A) . A Auto-ubiquitination assays in which the E3 acts both as an E3 and as proxy substrate were performed with GST-HHARI RBR , T7-Triad1 DAri , GST-Parkin RBR, and Flag-BRCA1/BARD1 and either UbcH5 WT [1] [2] [3] [4] . In RINGs, the linchpin is most often a basic residue (Arg or Lys) and is occasionally a neutral H-bonding residues such as Asn. HHARI contains an Asp residue in the structurally analogous position to the linchpin, and RBRs in general do not share a common residue that could fulfill the function of a hydrogen-bonding linchpin (Fig 1D) . This provides one possible explanation for HHARI RING1's failure to induce closed states of UbcH5~Ub.
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HHARI RING1 promotes open E2~Ub conformations
UbcH7 is a specialized E2 that can only perform transthiolation reactions, making it an RBR/HECT-specific E2 [6] . UbcH7 is active in vitro with many, if not all, RBR-type E3 ligases. Notably, C. elegans orthologs of UbcH7 and HHARI are vital partners in vivo [20] , prompting us to examine the effects of HHARI RING1 binding on UbcH7~Ub.
Unexpectedly, we discovered that in the absence of an E3, UbcH7-O-Ub populates closed conformations to a considerable extent. NMR CSP analysis of UbcH7-O-Ub compared to free UbcH7 reveals perturbed residues in the crossover helix of UbcH7 in addition to residues around the active site (Fig 2A) . The perturbations identify a surface similar to that seen in closed states of other E2~Ubs [1] [2] [3] [4] 35] . To verify this conclusion, we conjugated I44A-Ub to 15 N-UbcH7 because Ub I44A disrupts closed states of other E2~Ubs [1] [2] [3] . Indeed, residues of the UbcH7 crossover helix as exemplified by Q106 and S107 resonate at positions more similar to free UbcH7 than to UbcH7-O-Ub when I44A-Ub is the conjugated species ( Fig 2B and Appendix Fig S1) . Altogether, these data are consistent with UbcH7~Ub adopting closed conformations in the absence of an E3 that require surfaces that include the crossover helix of UbcH7 and the I44 surface of Ub (Fig 2A and B , and Appendix Fig S1) .
We next asked what effect HHARI RING1 binding has on UbcH7~Ub. Due to the high affinity of UbcH7 for HHARI RING1 [29] , residues affected by complex formation exhibit slow exchange behavior in 1 H-15 N-HSQC-type NMR experiments. This property leads to peak intensity loss rather than peak shifting in binding experiments ( Fig EV2A) . First, the effect of HHARI RING1 binding to unconjugated UbcH7 was analyzed to map the RING1-binding surface. 4  8  12  15  18  22  25  28  31  35  39  43  48  51  54  57  61  67  71  74  78  81  85  89  93  96  100  103  106  110  113  119  125  128  131  134  137  140  143  146  149 Fig S2) . For example, when UbcH7~Ub binds to RING1, the Ub Q49 resonance, which experiences the largest chemical shift upon Ub conjugation to UbcH7, moves back close to its position in the spectrum of free Ub ( Fig 3A and Appendix Fig S2) . The simplest explanation for this observation is that RING1 binding alters or disrupts contacts between Ub and UbcH7 in UbcH7~Ub. Importantly, chemical shifts for Ub residues within both RING1-bound UbcH7~Ub and UbcH5~Ub (Figs 1B and 3A, and Appendix Fig S2) are similar to those seen for free Ub. We propose that RING1 promotes open conformations of E2~Ub. We note that while Ub resonances of RING1-bound UbcH7~Ub are similar to those of free Ub, they are not identical, indicating that the environment of the Ub moiety may be affected by its proximity to RING1 in the complex ( Fig 3A and Appendix Fig S2) . For additional evidence of disruption of UbcH7~Ub closed conformations by RING1 binding, we used 1 H-13 C-HSQC-type experiments and published assignments to observe and interpret side chain resonances of 13 C-UbcH7 [39] . Side chain resonances of UbcH7 crossover helix residues shift upon conjugation to Ub, consistent with closed UbcH7~Ub states (as exemplified in Fig 3B and Appendix Fig S3) . Figure 3B compares three spectra: free 13 CUbcH7 (blue) and 13 C-UbcH7-O-Ub in the absence (black) and presence of HHARI RING1 (red). Notably, the methyl resonance of the surface-accessible crossover helix residue Ala110 is significantly perturbed upon conjugation of Ub to UbcH7, as evidenced by the lack of a (black) peak on or near the blue peak labeled Ala110 (Fig 3B) , indicating that the side chain of Ala110 interacts with Ub. Upon the addition of RING1 (red spectrum), the Ala110-CH 3 peak reappears at the chemical shift observed for Ala110-CH 3 in free 13 CUbcH7 (blue), evidenced by the red peak that overlays the blue Ala110 peak (Fig 3B and Appendix Fig S3) . These data corroborate the notion that UbcH7~Ub populates closed conformations in the absence of an E3 and that these are disrupted by HHARI RING1 binding. C-HSQC spectra of 13 C-UbcH7 (blue), 13 C-UbcH7-O-Ub (black), and HHARI RING1-bound 13 C-UbcH7-O-Ub (red) that includes the methyl (
resonance of the surface-exposed UbcH7 crossover helix residue, Ala110 (black arrow), is shown. The
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CH 3 peak of Ala110 either broadens dramatically or shifts to an unknown position in the spectrum of Katja K Dove et al Molecular insights into RBR Ub transfer mechanisms EMBO reports while RNF144 RING1 produced effects similar to HHARI RING1 upon binding to UbcH7-O-15 N-Ub ( Fig 3C and Appendix Fig S4) .
Thus, RBR-type RING1 domains share the ability to discourage closed UbcH7~Ub conformations, making them functionally distinct from canonical RING-type domains despite their structural similarities. Finally, we wondered whether HHARI RING1 can disrupt closed conformations of other E2~Ub species. Ubc13~Ub detectably populates closed conformations in the absence of E3 [35] . Indeed, addition of HHARI RING1 to Ubc13-O-15 N-Ub leads to chemical shifts of Ub resonances back toward their positions in free Ub, along the same trajectory as the "open" to "closed" perturbations ( Fig EV3) . Thus, the ability of HHARI RING1 to disrupt closed E2~Ub states is not limited to UbcH7. Closed E2~Ubs are associated with increased reactivity toward Lys amino groups [1] [2] [3] [4] [5] [6] .Therefore, a possible corollary to increased open E2~Ub conformations is an increase in transthiolation (reactivity toward Cys) as this is the relevant nucleophile in the context of RBR-type E3 ligases. However, we did not observe a difference between UbcH7~Ub reactivity toward free Cys in the absence versus presence of HHARI RING1 (Appendix Fig S5) .
Based on these data, we propose a mechanism in which not only does the RING1 of an RBR fail to promote closed E2~Ub states, but also it actively discriminates against them.
RING1 opening of E2~Ub enforces Ub transfer via the RING2 active site Cys
RBR E3s are active with E2s that are also active with canonical RING-type E3s [6, 8, 9, 15, [25] [26] [27] [28] . This implies that the E2~Ub must distinguish between its two reaction modes (transthiolation and aminolysis) based on the type of E3 ligase with which it interacts. Open E2~Ub states are minimally reactive toward Lys and require activation for canonical RING-type Ub transfer [1] [2] [3] [4] . We wondered whether there would be negative consequences if an RBR RING1 could also stabilize closed, aminolysis-activated E2~Ubs as seen with canonical RINGs. However, our efforts to generate a HHARI RING1 that activates the E2~Ub for aminolysis by mutating positions known to be critical in canonical RING domains failed. We took an alternative approach to assess the consequence of having aminolysis activity in the context of an RBR E3 by replacing the RING1 domain within the HHARI RING1-IBR-RING2 (WT-RBR domain) construct with the Ubox domain of E4BU to generate a Ubox-IBR-RING2 (UBR) hybrid (Fig 4A) . Ubox domains are E2-binding domains that contain RING-like folds, but do not ligate Zn 2+ and are therefore more likely to fold successfully within a hybrid construct. Importantly, the Ubox domain of E4BU has been shown to activate UbcH5~Ub for aminolysis via promotion of closed E2~Ub conformations [1] . We posited that an RBR with the ability to activate E2~Ub for aminolysis might circumvent the obligate transthiolation reaction through the active site Cys residue in RING2. In in vitro auto-ubiquitination assays where the RBR E3 acts as a proxy substrate, Ub transfer occurs through the active site Cys as the active site mutation C357A essentially abrogates ubiquitination activity of HHAR-I RBR (Fig 4B, left panel) . Remarkably, this is not the case for reactions carried out by the UBR hybrid as the active-site-dead (C357A) version retains substantial auto-ubiquitination activity (Fig 4B, right panel) . The result implies that UbcH5~Ub transfers its Current models of RBR-type mechanisms assume a two-step process for Ub transfer: First, Ub is transferred from the E2~Ub to the active site Cys on RING2 to form an E3~Ub, and second, Ub is transferred from the E3~Ub to a substrate amino group. In the case of HOIP RBR-LDD, it has been shown that the I44 surface is not required for binding of the acceptor Ub [9] . We therefore postulated that the I44 surface might be required for the first step of the RBR Ub transfer mechanism. To test this hypothesis, we compared discharge rates for E2~Ub charged with either WT-Ub or mutant Ub prior to incubation with Parkin RBR . In this assay, the disappearance of E2~Ub can be observed directly by SDS-PAGE (in the absence of reducing agent). UbcH7~Ub
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WT disappears rapidly when incubated with Parkin, whereas the UbcH7~Ub I44A is stable in the presence of Parkin indicating that Ub transfer from the E2~Ub to Parkin RING2 is impaired when the Ub to be transferred is I44A-Ub (Fig 5C) . Because E3~Ub intermediates for RBR E3s are often short-lived and therefore difficult to detect, it is not possible to say whether the observed disappearance of the E2~Ub is via transfer to the Parkin RING2 active site Cys or merely hydrolysis. To address this question, we took advantage of RING2 mutations in HOIP and HHARI (H887A and H359A, respectively) that stabilize the E3~Ub [29, 41] . In assays with HOIP H887A or HHARI H359A as the E3, both the UbcH7~Ub and the E3~Ub conjugates are detected. Single mutations in the Ub hydrophobic surface show both reduced disappearance of the E2~Ub (similar to Parkin) and, importantly, decreased generation of E3~Ub (Figs 5D and E, and EV4B). These experiments provide strong evidence that the hydrophobic patch of Ub plays a key role in the first step of the RBR mechanism, namely for Ub transfer from the RING1-bound E2 to the Cys on RING2. Whether the Ub hydrophobic patch is also required for the second step of Ub transfer by RBR E3s remains to be addressed in future studies.
HHARI RING2 binds to the hydrophobic patch of Ub
A possible explanation for the observation that the hydrophobic patch of Ub is required for transfer of Ub from the E2 onto the E3 active site is that the Ub surface binds to the RING2 domain to recruit its active site to the E2~Ub. Consistent with this notion, some RBR RING2 domains retain weak but detectable Ub transfer activity independent of RING1, suggesting that when protein concentrations are high enough in vitro, RING2 can recruit an E2~Ub on its own [9, [41] [42] [43] [44] . We reasoned that an interaction between free Ub and RING2 is likely to be of very low affinity. Because Ub is extremely soluble, we performed NMR binding experiments using 100 lM 15 N-HHARI RING2 (residues 325-396) and high concentrations of Ub (1 mM; Fig 6A) . A subset of resonances disappear or shift in the presence of WT-Ub but not of V70A-Ub, the Ub mutant that most affects HHARI activity (Figs 5A and 6A top versus middle panels). The result has two implications: (i) The effects observed with WTUb are not merely due to the very high Ub concentrations used and (ii) there is a direct, albeit low affinity interaction between RING2 and the hydrophobic surface of Ub. An NMR solution structure of HHARI RING2 has been solved, and therefore, the NMR spectrum is assigned [45] , allowing perturbed residues to be identified and mapped onto the RING2 domain structure. The resulting surface forms a contiguous patch in proximity to the active site Cys357 and extends into the linker between IBR and RING2 ( Fig 6B) . We were surprised to see involvement of the linker which is not observed in the crystal structure [29] , so we repeated the binding experiment using a RING2 construct that lacks most of the RING2-IBR linker (HHARI RING2-DL, residues 336-395). Remarkably, binding of Ub to 15 N-HHARI RING2-DL is substantially reduced, consistent with the linker serving as part of the binding interface (Fig 6A, bottom  panel) . Mutations in HHARI residues most highly perturbed by Ub binding were tested for functional consequences in auto-ubiquitination assays. In the context of HHARI RBR , Trp336, Glu352, and Arg363 were each mutated to Ala, and Thr341 was changed to an Asn to mimic the pathogenic mutation T415N in the analogous conserved residue in Parkin (Fig 6C) . Strikingly, T341N decreases HHARI's ligase activity substantially and both W336A and E352A show a moderate reduction of ubiquitination activity while R363A has no observable effect (Fig 6D) . NMR binding experiments confirm that the mutations that decrease ligase activity also decrease Ub binding to HHARI RING2 (Fig 6E) . Together, the results corroborate that RING2 and linker residues are important for both Ub binding and HHARI activity, leading us to propose that the hydrophobic surface on the donor Ub binds and recruits RING2 and that this step is crucial for overall RBR activity.
Discussion
Until a few years ago, RBR E3 ligases were considered to be RINGtype E3 ligases because they were thought to contain two RING domains based on primary sequence analysis. Today, we know that only RING1 domains adopt a fold similar to canonical RING trapping of the E3~Ub thioester with WT-Ub [29, 41] . While a HOIP~Ub thioester species is observed when UbcH7 was charged with WT-Ub, no detectable transfer occurs with the I44A-Ub conjugate (left). Similarly, V70A-Ub shows reduced formation of the HHARI~Ub thioester (right). In addition to blotting for HA-Ub, the blot on the right was also blotted for GST-HHARI. actively favor open E2~Ub conformations. This strategy ensures that the transfer of Ub proceeds via the active site Cys on RING2 and therefore that the type of product generated (e.g. mono-or a specific poly-Ub chain) is determined by the RBR E3 and not by the E2 (Fig 7B) . We propose that the disfavoring of closed E2~Ub states by RING1 is a common mechanistic feature of RBR E3s for several reasons. Katja
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First, we demonstrate by NMR that the RING1 domain from another RBR, RNF144, also promotes open UbcH7~Ub states (Fig 3C) . Second, the RBR E3s HHARI, Parkin, TRIAD1, and HOIP all exhibit robust Ub transfer activity with UbcH5 L104Q in vitro ( Figs 1A and   EV1 ). Third, not promoting closed E2~Ub states is functionally important as it prevents off-target ubiquitination events catalyzed by the E2~Ub (Fig 4) . In sum, RING1 domains act in an opposite manner to canonical RINGs in that they actively inhibit E2~Ub closed states and consequently, suppress E2~Ub aminolysis reactivity and therefore E2 specificity. Such a strategy can be rationalized in the context of the overall RBR mechanism in which an E2~Ub must transfer Ub specifically onto a Cys (the active site of RING2)
and not to a Lys residue. RBR E3 ligases are rendered catalytically inactive when their active site Cys is mutated to an Ala proving that the Ub transfer occurs through an obligate covalent E3~Ub conjugate [6, [8] [9] [10] [11] 22, 23] . Therefore, Ub transfer from the E2~Ub to Lys residues on either the E3 itself or another protein in its vicinity would be off-target and likely detrimental to the cellular processes that RBR E3s regulate. This unique feature of RBR RING1 domains allows RBR E3s to accept Ub from a variety of E2~Ubs including E2s that are able to transfer Ub onto either Lys or Cys, while ensuring that Ub transfer occurs through the active site Cys on RING2. Such discrimination is crucial, as in all cases known to date, it is the enzyme that carries out the final aminolysis reaction that
RING1 binding promotes E2~Ub in open states
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A B [15] . In such reactions, the E2~Ub acts as a supplier of Ub for the E3, but must not modify substrates directly. Altogether, these properties enable use of the same E2s by both RING-type and RBR E3s to follow the adage "The last guy holding the activated Ub/Ubl gets to determine the product" [47] . Consistent with this general principle, the only available structure of a HECT/E2~Ub complex shows the E2~Ub in an extended conformation with non-covalent interactions between Ub and the HECT domain C-lobe, suggesting that HECT-type E3s may also promote open E2~Ub states [7] . However, the open E2~Ub state appears to be stabilized by interactions between Ub and the HECT active-site-containing C-lobe, while our NMR results show that the E2-binding domain (RING1) of RBR E3s actively disfavors E2~Ub closed states on its own. Likely, this feature is particularly important for RBR E3s like HHARI that can bind E2~Ub in their auto-inhibited states where RING1 and RING2 are very far removed as it serves to inhibit premature Ub transfer from the bound E2~Ub before an activation event allows recruitment of RING2 to occur.
E2
Given the structural similarities between canonical RINGs and RBR RING1s, their opposite effects upon binding E2~Ub is surprising. As pointed out above, RING1 domains lack the basic linchpin residue responsible for stabilizing closed E2~Ub states, but this does not adequately explain why RING1 binding actively promotes open E2~Ubs. One possibility is that RING1 binds Ub in the context of E2~Ub as has been suggested for Parkin [33] , but our NMR data for HHARI and RNF144 RING1 binding to E2~Ub presented here do not indicate Ub binding by RING1. Instead, NMR binding experiments with either UbcH5 or UbcH7 identified an E2 surface that includes residues of the crossover helix that are not perturbed by canonical RING binding, suggesting that RING1 binds to a shifted or expanded surface on the E2. Notably, this "new" E2-binding surface overlaps with that contacted by Ub in closed E2~Ub states, suggesting that RING1 binding may effectively compete with Ub binding, thereby disfavoring closed conformations. The details of HHARI RING1: E2~Ub must await further structural characterization.
Our finding that mutation of Ub hydrophobic patch residues affects the first Ub transfer step for HHARI, Parkin, and HOIP led to our subsequent discovery of a Ub-binding surface on RING2. Although there are differences in severity among different Ub hydrophobic patch mutations for different RBR E3 ligases, all three E3s tested exhibit reduced activity with V70A-Ub and Q49E-Ub. Consistent with the modest degree of sequence conservation in RBR RING2s, we speculate that the Ub-binding surface on RING2 is composed of some different residues in each RBR E3 (Figs 5A and EV4B). That the composition of the Ub-binding regions on RING2s varies is not particularly surprising. Various Ub-binding domains that use the same Ub hydrophobic patch differ in primary and tertiary structures, indicating that there are many possible binding modes between the Ub hydrophobic patch and a binding motif. We therefore propose that RING2 binding to the hydrophobic patch of Ub serves to recruit RING2 to the RING1-bound E2~Ub and that this feature is shared among RBR E3 ligases.
While this study was under review, a crystal structure of HOIP RBR-LDD bound to UbcH5~Ub was published that is consistent with the main tenets of the model presented here [48] . The structure reveals a myriad of interactions among the E3, E2, and Ub that involve multiple copies of HOIP, UbcH5, and Ub in the asymmetric unit. Nevertheless, a number of features and interactions observed in the crystal are analogous to what we report here from solution measurements. First, the E2~Ub bound to RING1 of the HOIP RBR-LDD is in an open conformation. In the crystal, this Ub moiety forms an extensive interface with the E3 including residues from the RING1-IBR linker and the IBR. Our work demonstrates that HHARI and RNF144 RING1 constructs (which include the RING1-IBR linker) are sufficient to induce open E2~Ub conformations, so the importance of additional contacts with the IBR during the first step of ubiquitin transfer remains to be addressed. Second, the hydrophobic patch of this Ub makes contacts to the IBR-RING2 linker and RING2 of another HOIP molecule in the crystal and this interaction is centered around Ub residues I44 and V70, in agreement with our assays showing that I44A-Ub and V70A-Ub significantly impair Ub transfer with HOIP RBR-LDD ( Fig EV4B) . As the HOIP/E2~Ub structure is of UbcH5~Ub which is already in open states when unbound to an E3, our study provides an important additional insight that cannot be inferred from the crystal structure: RING1 binding actively opposes closed states, rather than just failing to promote them.
Structural and biochemical investigations have provided rationales for the effects of many patient mutations in Parkin, but the T415N mutation has remained enigmatic [49] . Substitution of Thr415 with Asn decreases ligase activity substantially though it alters neither the structure nor solubility of Parkin [43, 50, 51] . Thr415 is proposed to be involved in a hydrogen-bonding network around the active site that is required for catalysis [43] . In our study, we found that the analogous mutation in HHARI, T341N, also decreases ligase activity and, importantly, decreases Ub binding to HHARI RING2 (Figs 6D and E, and EV5B). Thus, our discovery of a Ub-binding site composed of residues from RING2 and its proximal linker provides another possible mechanistic explanation for the loss of function associated with this Parkin mutation. Our results support an earlier report that peptides spanning the Parkin IBR-RING2 linker bind Ub in a peptide array assay [40] . Thr415 is conserved in orthologs of Parkin as well as orthologs in HHARI. Altogether, the observations lead us to propose that the pathogenic Parkin T415N mutation disrupts Ub binding and consequently disables the recruitment of RING2 to the bound E2~Ub conjugate to enable the transfer of Ub onto the Parkin active site. It remains possible that the detrimental effect of T415N on Parkin activity is due to a combination of the loss of Ub binding to RING2 and the loss of a critical hydrogen-bonding network around the active site [43] .
A common feature of RBR E3 ligases is that they exist in autoinhibited states characterized by low activity [8, 10, [29] [30] [31] [32] [33] [34] 40, 52] . Structures of HHARI and Parkin reveal two common features that define the auto-inhibited states [29] [30] [31] [32] [33] [34] . First, the active site Cys on RING2 is at least partially buried by another domain. Second, the E2-binding RING1 domain and the RING2 domain are separated by large distances (Fig 7A) . Both features imply that RBR E3 ligases must undergo major rearrangements to become active enzymes. Details of release of auto-inhibition are specific for each RBR E3 and are not yet fully defined [8, 10, [29] [30] [31] [32] [33] [34] 40, 52] . However, they share one common feature: The E2-binding RING1 domain and the active-site-containing RING2 domain must come together for transfer of Ub from the E2~Ub onto the E3 active site. In autoinhibited conformations of HHARI and Parkin, the domains of the RBR are connected by long flexible linkers that presumably allow the domains to adopt positions that are quite remote from one another. Other than a short helix referred to as the REP (repressor) element in Parkin, linkers between IBR and RING2 domains are either not observed or are unstructured in existing crystal structures of HHARI and Parkin [29] [30] [31] [32] [33] [34] 52] . However, the linker proximal to HHARI RING2 is observed in solution by NMR and in crystal structures of HOIP RING2-LDD and HOIP RBR-LDD bound to E2~Ub where in all cases it forms a short helix (Fig EV5C and [41, 45, 48] ). Importantly, several of the HHARI residues that we observed to be perturbed upon Ub binding are in the part of the IBR-RING2 linker that is seen to form a helix. We propose that the linker is extended and/or disordered in auto-inhibited states, resulting in an incomplete RING2 Ub-binding surface that will have little or no ability to bind Ub. Upon release of the inhibitory domain(s), the linker could undergo a coil-to-helix transition to complete the Ub-binding site on RING2, enabling it to be recruited to the conjugated Ub moiety bound at RING1. We propose that open E2~Ub conformations induced by RING1 binding expose the hydrophobic patch on the conjugated Ub to allow Ub within the RING1-bound E2~Ub to contact RING2 and ensure proper transfer of Ub onto the RING2 active. Although the structural details by which this mechanism is carried out may vary among RBRs, we believe that the main features defined here will be shared among them.
In closing, we note that our original proposal that RBR E3s are RING/HECT hybrids remains true in a structural sense. But findings reported here show clearly that the RBRs have evolved their own distinctive mechanistic strategies to achieve their function. Most remarkably, the centerpiece of the canonical RING allosteric mechanism for Ub transfer has been turned on its head by the RBRs.
Materials and Methods
Cloning and constructs
The following constructs were used in this study. If not stated otherwise, the following constructs are human and full-length: HHARI-RBR (aa 177-395), HHARI-RING2 (aa 325-396), HHARI-RING2-ΔL (aa 336-395), HHARI-RING1 (aa 177-270), GST-Parkin-RBR (aa 217-465, rat), TRIAD1-ΔARI (aa 1-348), RNF144 RING1 (aa 2-108), HOIP-RBR-LDD (aa 697-1,072), HOIP-RING2 (aa 853-1,072), E4BU (aa 1,092 . UbcH5c, UbcH7, His 6 -Ubc13, BRCA1/BARD1, E4BU, GST-HHARI-RBR, GST-Parkin-RBR, HOIP-RBR-LDD, HOIP-RING2 were purified as previously described [6, 8, 35, 36, 41, 53] . GST-E4BU-HHARI hybrid was purified as GST-HHARI-RBR.HHARI RING1 and RING2 constructs were purified using GST columns (GE Healthcare and Life Sciences) in 50 mM Tris, 200 mM NaCl, pH 8.0, and eluted with 10 mM glutathione. GST-tags cleaved with thrombin (Sigma-Aldrich) and removed by size-exclusion chromatography (25 mM NaPO 4 , 150 mM NaCl, pH 7.0). His 6 -T7-TRIAD1-ΔARI and His 6 -SUMO-RNF144-RING1 were purified using Ni 2+ affinity chromatography.
His 6 -SUMO-tag was removed from RNF144-RING1 using SUMO protease in 50 mM Tris, 200 mM NaCl, 1 mM DTT, pH 8.0. Finally, size-exclusion chromatography in 25 mM NaPO 4 , 150 mM NaCl, pH 7.0, was performed on His 6 -T7-TRIAD1-ΔARI and cleaved RNF144-RING1.
E2~Ub discharge assays
2 lM wheat E1, 20 lM UbcH7 or UbcH5, 10 lM of Ub or HA-Ub (WT or mutant), 5 mM ATP were mixed at 37°C in 25 mM NaPO 4 , 150 mM NaCl, pH 7.0 for 20 min. Charging reactions were quenched with the addition of 0.1 units of apyrase (Sigma-Aldrich)/ 10 ll reaction for 5 min. A zero-minute time point was taken using non-reducing SDS-PAGE load dye prior to incubation with either free nucleophile or E3. Cys reactivity assays: Charging reactions were diluted twofold and incubated at 37°C with a final concentration of either 5 mM Cys in the absence or presence of 75 lM E3 (HHARI RING1). Reactions were quenched at given time points by addition of non-reducing SDS-PAGE load dye. Products were visualized with Coomassie blue stain. Parkin discharge assays: Charging reactions were diluted twofold and incubated at 37°C with a final concentration of 4 lM GST-Parkin-RBR . Reactions were quenched at given time points by addition of non-reducing SDS-PAGE load dye. UbcH7~Ub discharge and E3-Ub product formation were visualized by Western blotting for HA-Ub (HA antibody from Life Tein, LT0422). HOIP~Ub/HHARI~Ub capture assay: 50 ll of charging reactions was quenched with addition of 5 ll apyrase for 5 min at room temperature (RT). Time point zero was taken immediately prior to addition of H887A-HOIP RBR-LDD or H359A-HHARI RBR to a final concentration of 5 lM E3. Reactions were performed at RT and quenched at given time points by addition of non-reducing SDS-PAGE load dye. Product formation was visualized by Western blotting for HA-Ub and GST (HHARI).
# Correction added on 20 March 2017, after first online publication: the starting amino acid of E4BU has been corrected here and in the Appendix file. 
